South Korea to Offer Free HPV Vaccinations to 12-Year-Old Boys from May 6

South Korea is taking a significant step forward in public health by extending free Human Papillomavirus (HPV) vaccinations to 12-year-old boys through its national immunization program, commencing May 6. This proactive measure, announced by the Korea Disease Control and Prevention Agency (KDCA), broadens the existing program which previously targeted adolescent girls and low-income women. The inclusion of boys is a crucial development, acknowledging that HPV infections are not exclusive to women and can lead to serious health issues in men, including genital warts, anal cancer, and oropharyngeal cancer. The KDCA emphasizes that vaccinating both sexes is essential for strengthening the prevention of HPV-related diseases across the population. This policy aligns South Korea with a growing global consensus on the importance of comprehensive HPV vaccination. The HPV vaccine, specifically the 4-valent type, is supported by robust evidence of its effectiveness and safety, as confirmed by international bodies like the US Centers for Disease Control and Prevention (CDC). Globally, 147 countries, including 37 of the 38 OECD member states, have integrated HPV vaccination into their national programs. The KDCA's decision reflects recommendations from its expert committee, which highlighted the vaccine's role in reducing the overall disease burden on society. By making the vaccine accessible to young boys, South Korea aims to foster a healthier future, preventing a range of debilitating conditions and contributing to the long-term well-being of its citizens. The agency is ensuring thorough preparation to facilitate smooth access for eligible adolescents and their guardians.